InfuSystem Holdings, Inc. (FRA:1TZ)

Market Cap	247.94M +44.0%
Revenue (ttm)	125.46M +2.5%
Net Income	7.48M +68.4%
EPS	0.36 +68.9%
Shares Out	n/a
PE Ratio	34.10
Forward PE	25.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	750
Open	12.30
Previous Close	12.30
Day's Range	12.20 - 12.30
52-Week Range	6.05 - 13.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About InfuSystem Holdings

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 473
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1TZ

Financial Performance

In 2025, InfuSystem Holdings's revenue was $143.44 million, an increase of 6.36% compared to the previous year's $134.86 million. Earnings were $6.63 million, an increase of 182.60%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error